Abeona Therapeutics Inc.
ABEO
$5.59
$0.061.09%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 14.54M | 5.82M | 400.00K | 400.00K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.54M | 5.82M | 400.00K | 400.00K | -- |
| Cost of Revenue | 32.55M | 30.24M | 29.68M | 33.92M | 37.09M |
| Gross Profit | -18.01M | -24.42M | -29.28M | -33.52M | -37.09M |
| SG&A Expenses | 74.75M | 65.03M | 53.93M | 41.02M | 32.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 107.29M | 95.27M | 83.61M | 74.94M | 69.61M |
| Operating Income | -92.75M | -89.45M | -83.21M | -74.54M | -69.61M |
| Income Before Tax | 66.24M | 71.28M | 82.67M | 72.75M | -44.19M |
| Income Tax Expenses | 102.00K | 100.00K | 315.00K | 15.51M | -- |
| Earnings from Continuing Operations | 66.14 | 71.18 | 82.35 | 57.24 | -44.19 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 66.14M | 71.18M | 82.35M | 57.24M | -44.19M |
| EBIT | -92.75M | -89.45M | -83.21M | -74.54M | -69.61M |
| EBITDA | -90.05M | -86.90M | -80.98M | -72.43M | -67.56M |
| EPS Basic | 1.30 | 1.36 | 1.54 | 1.01 | -0.88 |
| Normalized Basic EPS | -0.99 | -0.95 | -0.84 | -1.00 | -0.55 |
| EPS Diluted | 0.93 | 0.99 | 1.17 | 0.64 | -1.33 |
| Normalized Diluted EPS | -0.92 | -0.88 | -0.77 | -0.93 | -0.57 |
| Average Basic Shares Outstanding | 218.60M | 211.76M | 205.23M | 199.07M | 186.55M |
| Average Diluted Shares Outstanding | 232.72M | 225.88M | 219.34M | 213.18M | 197.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |